Zhejiang Shengda Pharm (603079) — Capital Reinvestment Ratio

Latest as of September 2025: 0.80x

Zhejiang Shengda Pharm (603079) has a Capital Reinvestment Ratio of 0.80x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥45.27 Million) in capital expenditures (CN¥36.15 Million). Check Zhejiang Shengda Pharm (603079) tangible equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.80x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥45.27 Million
CNY

Capital Expenditures

CN¥36.15 Million
CNY

Data as of

Sep 2025
Most recent filing

Zhejiang Shengda Pharm Capital Reinvestment Ratio (2012–2025)

This chart tracks Zhejiang Shengda Pharm's Capital Reinvestment Ratio across 14 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Zhejiang Shengda Pharm.

Annual Capital Reinvestment Ratio for Zhejiang Shengda Pharm (2012–2025)

Year-by-year Capital Reinvestment Ratio for Zhejiang Shengda Pharm from 2012 to 2025. See cash generation quality of Zhejiang Shengda Pharm to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2025 1.05x CN¥138.88 Million CN¥145.68 Million ▼ -8.7%
2024 1.15x CN¥147.88 Million CN¥169.85 Million ▼ -69.9%
2023 3.82x CN¥64.42 Million CN¥245.93 Million ▲ +145.7%
2022 1.55x CN¥40.72 Million CN¥63.26 Million ▲ +15.7%
2021 1.34x CN¥74.46 Million CN¥99.96 Million ▲ +425.3%
2020 0.26x CN¥333.20 Million CN¥85.15 Million ▼ -91.9%
2019 3.17x CN¥58.55 Million CN¥185.88 Million ▲ +94.8%
2018 1.63x CN¥88.69 Million CN¥144.52 Million ▲ +231.3%
2017 0.49x CN¥95.33 Million CN¥46.88 Million ▼ -33.2%
2016 0.74x CN¥73.00 Million CN¥53.77 Million ▲ +408.6%
2015 0.14x CN¥148.07 Million CN¥21.44 Million ▼ -78.3%
2014 0.67x CN¥34.40 Million CN¥22.93 Million ▲ +208.8%
2013 0.22x CN¥105.28 Million CN¥22.72 Million ▼ -75.3%
2012 0.88x CN¥110.08 Million CN¥96.32 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow